Infographic: The fetal frontier A review of current and emerging fetal therapies for genetic diseases
Topic overview
This review examines current and emerging prenatal treatments for genetic diseases, including enzyme replacement, stem cell transplantation, and gene therapy. Early fetal intervention leverages unique developmental advantages such as a permissive blood-brain barrier and naive immune system to prevent postnatal consequences of hereditary conditions.
Key takeaways
- Prenatal diagnosis now enables early detection of aneuploidies and single-gene disorders, creating opportunities for fetal intervention.
- Fetal treatment leverages unique developmental advantages: permissive blood-brain barrier, naive immune system, favorable vector-to-tissue ratio.
- Current fetal therapies span enzyme replacement, protein therapy, stem cell transplantation, and gene-targeted interventions.
- Minimally invasive delivery techniques now allow safe in utero treatment of previously inaccessible fetal patients.
- Early intervention can prevent irreversible postnatal damage in metabolic, neurodegenerative, hematologic, and hormonal genetic disorders.
Comments